CN107007646A - A kind of nutrition compound of assisting in preventing and treating cancer - Google Patents
A kind of nutrition compound of assisting in preventing and treating cancer Download PDFInfo
- Publication number
- CN107007646A CN107007646A CN201710149560.7A CN201710149560A CN107007646A CN 107007646 A CN107007646 A CN 107007646A CN 201710149560 A CN201710149560 A CN 201710149560A CN 107007646 A CN107007646 A CN 107007646A
- Authority
- CN
- China
- Prior art keywords
- drug
- assisting
- preventing
- treating cancer
- nutrition compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 34
- 201000011510 cancer Diseases 0.000 title claims abstract description 31
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 18
- 230000035764 nutrition Effects 0.000 title claims abstract description 17
- 150000001875 compounds Chemical class 0.000 title claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 46
- 229940079593 drug Drugs 0.000 claims abstract description 35
- 150000004676 glycans Chemical class 0.000 claims abstract description 18
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 18
- 239000005017 polysaccharide Substances 0.000 claims abstract description 18
- 241000721047 Danaus plexippus Species 0.000 claims abstract description 15
- 235000007091 Chlorella pyrenoidosa Nutrition 0.000 claims abstract description 10
- 241000233866 Fungi Species 0.000 claims abstract description 9
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 238000000855 fermentation Methods 0.000 claims abstract description 5
- 230000004151 fermentation Effects 0.000 claims abstract description 5
- 239000012141 concentrate Substances 0.000 claims abstract description 4
- 244000249214 Chlorella pyrenoidosa Species 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 241001327634 Agaricus blazei Species 0.000 claims description 5
- 235000009508 confectionery Nutrition 0.000 claims description 4
- 240000002853 Nelumbo nucifera Species 0.000 claims description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 3
- -1 adjutant Substances 0.000 claims description 3
- 238000013329 compounding Methods 0.000 claims description 3
- 235000005686 eating Nutrition 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims 1
- 229930182470 glycoside Natural products 0.000 claims 1
- 150000002338 glycosides Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 231100000331 toxic Toxicity 0.000 abstract description 9
- 230000002588 toxic effect Effects 0.000 abstract description 9
- 230000036541 health Effects 0.000 abstract description 6
- 241000411851 herbal medicine Species 0.000 abstract description 6
- 239000003053 toxin Substances 0.000 abstract description 4
- 231100000765 toxin Toxicity 0.000 abstract description 4
- 241000294142 Vascellum Species 0.000 abstract description 2
- 230000000593 degrading effect Effects 0.000 abstract description 2
- 238000000605 extraction Methods 0.000 abstract description 2
- 231100000206 health hazard Toxicity 0.000 abstract description 2
- 229910001385 heavy metal Inorganic materials 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 241000195652 Auxenochlorella pyrenoidosa Species 0.000 abstract 2
- 230000036039 immunity Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 239000004383 Steviol glycoside Substances 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- 235000008935 nutritious Nutrition 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 229930182488 steviol glycoside Natural products 0.000 description 4
- 235000019411 steviol glycoside Nutrition 0.000 description 4
- 150000008144 steviol glycosides Chemical class 0.000 description 4
- 235000019202 steviosides Nutrition 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 240000008397 Ganoderma lucidum Species 0.000 description 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 2
- 206010024769 Local reaction Diseases 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000118 anti-neoplastic effect Effects 0.000 description 2
- 230000003356 anti-rheumatic effect Effects 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000005058 diapause Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001093 holography Methods 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000004719 natural immunity Effects 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 101710186708 Agglutinin Proteins 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 101710146024 Horcolin Proteins 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 101710189395 Lectin Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 101710179758 Mannose-specific lectin Proteins 0.000 description 1
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 1
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010061924 Pulmonary toxicity Diseases 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 239000000910 agglutinin Substances 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000026721 nail disease Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 231100000374 pneumotoxicity Toxicity 0.000 description 1
- 230000007047 pulmonary toxicity Effects 0.000 description 1
- 238000011127 radiochemotherapy Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of nutrition compound of assisting in preventing and treating cancer, using chlorella pyrenoidosa as monarch drug in a prescription, using Herba Saussureae Involueratae culture as ministerial drug, using fungi polysaccharide as adjutant, wherein the crude drug weight ratio of monarch drug in a prescription, ministerial drug and adjutant is 7:2:1.The nutrition compound of the assisting in preventing and treating cancer is applied to personalized health service, and the nutrition compound is equipped with natural plants and fungi polysaccharide using chlorella pyrenoidosa as carrier, reaches and excludes toxin, dredging vascellum, strengthens immune comprehensive function;Formula production is extracted based on natural plants fermentation and concentrates and purifies bioengineering, the active ingredients of high efficiency extraction Chinese herbal medicine, while the agriculture chemical heavy-metal residual in Chinese herbal medicine of degrading, reduce its toxic side effect, product is applied to personalized health service, ecological safety, formula is reasonable, without any potential health hazard.
Description
Technical field
The present invention relates to a kind of formula for optimizing nutritional mode assisting in preventing and treating cancer with non-drug, more particularly to a kind of auxiliary
The nutrition compound of anti-curing cancers.
Background technology
Counted according to the World Health Organization, China in 2015 there are more than 280 ten thousand people to die from cancer, average daily 7500 people.Cancer
It is one of main cause of the death of China." Chinese cancer occurrence numbers and cancer related mortality number are annual all with astonishing
Speed rises.
The global problem for the treatment of of cancer, there is presently no the method for suiting the medicine to the illness of healing.But also there are a few peoples to put down
All, are easily treated, and life is continued.And hospital's chemicotherapy is removed in most people selection, or take Chinese herbal medicine.These are basic
Method all plays good effect, but these methods also toxic side effect simultaneously.
It is exactly while killing tumor cell, also to have killed human normal cell using the side effect of chemicotherapy mode.
The recent toxicity of toxicity point and toxicity at a specified future date and complication.
Recent toxic reaction is divided into local reaction again(Such as local tissue necrosis, angiitis obliterans)And systemic reaction(Bag
Include alimentary canal, hemopoietic system, cardiac response, pulmonary toxicity reaction, renal dysfunction and other reactions etc.).Toxic reaction master at a specified future date
If reproductive dysfunction and carcinogenesis, teratogenesis etc..
There is complication and common are infection, bleeding, perforation, uric acid crystal etc., local reaction:Phlebitis, local tissue necrosis.
Bone marrow suppression causes blood platelet, red blood cell, hemoglobin to reduce, can also have fatigue and weak, resistance decline, easy infection,
Heating, bleeding, alopecia, dysacousis, fash, face or flush, nail deformation, osteoporosis, etc. performance.These diseases
Change causes body immunity drastically to decline, and Relapse rate brings considerable distress to patient and household.Some patients can't stand putting
Pain is treated, is changed to take Chinese herbal medicine, but toxicity of overeating is big, also can't stand.
If naturopathy and biological nutrition therapy can be used, the state of an illness can be alleviated, and no pain, the side that has no side effect
Method, it has also become the serious hope of numerous cancer patients and demand.
The content of the invention
Present invention aim to address the defect present in prior art, for the most of chemicotherapies of cancer bring it is obvious
Toxic side effect, the problem to be solved in the present invention is:
(1)Which material, and reasonable compatibility are selected, any potential toxic side effect can be just avoided the occurrence of.
(2)How patient acid-base balance, discharge degraded vivotoxin, because cancer constitution be acid could be adjusted.
(3)How could patient avoid cancer complication, softening and dredging blood vessel is given balanced nutritious.
(4)How patient suffering can be reduced with anti-inflammatory analgesic.
(5)How effectively could recover and strengthen patient's immunity.
The invention provides a kind of nutrition compound of assisting in preventing and treating cancer, the nutrition compound of the assisting in preventing and treating cancer is fitted
For personalized health service, the nutrition compound is equipped with natural plants and fungi polysaccharide using chlorella pyrenoidosa as carrier, reached
To the comprehensive function that exclusion toxin, dredging vascellum, enhancing are immune;It is biological that formula production extracts concentrating and purifying with natural plants fermentation
Engineering is guide, the active ingredients of high efficiency extraction Chinese herbal medicine, while the agriculture chemical heavy-metal residual in Chinese herbal medicine of degrading,
Its toxic side effect is reduced, product is applied to personalized health service, and ecological safety, formula is reasonable, without any potential health
Harm.
The technical solution adopted in the present invention is:A kind of nutrition compound of assisting in preventing and treating cancer, with chlorella pyrenoidosa
For monarch drug in a prescription, using Herba Saussureae Involueratae culture as ministerial drug, using fungi polysaccharide as adjutant, the wherein crude drug weight of monarch drug in a prescription, ministerial drug and adjutant
The ratio between be 7:2:1.
Monarch drug in a prescription is chlorella pyrenoidosa, rises and excludes toxin, and there is provided balanced nutritious effect for regulation acid-base balance;Pyrenoids is small
Ball algae is the general natural disposition monoplast green alga of green door Chlorella, and it is four that its vegetative propagation, which is one point, and about 20 hours, one slender
Born of the same parents are just split into four, there is extremely strong procreation ability.The anticancer that chlorella pyrenoidosa possesses is indicative more prominent, contains holography
Embryo differentiation accelerator is more, and anti-cancer and cancer-preventing is very competent, and it can promote holographic embryo of the diapause in cancer area to pass through cancer well
Area, carries out normal differentiation and development, so as to reach the purpose of anti-curing cancers.
Ministerial drug is Herba Saussureae Involueratae culture, auxiliary monarch drug in a prescription treatment main symptom, main softening and dredging blood vessel function.Herba Saussureae Involueratae is trained
Foster thing not only contains the active component close with natural snow lotus, and also has many pharmacological activity suitable therewith.It is led
Want pharmacological action analgesia, anti-inflammatory, antirheumatic;Suppress platelet aggregation, reducing blood lipid, improve blood circulation, have to immune system
Adjustment effect.
Adjutant is fungi polysaccharide, and strengthen immunity coordinates monarch-minister drug treatment accompanying symptoms.
Further, described fungi polysaccharide is Agaricus Blazei Murrill polysaccharide.The antineoplastic component of Agricus blazei mainly has nucleic acid, outer
Source agglutinin, sterol and aliphatic acid and polysaccharide.The polysaccharide body content of Agricus blazei is up to 6.55g/100g, is 5 times of ganoderma lucidum.
Unique β-(1-6)- D- glucose structures directly act on immunity, can fast lifting natural immunity cell growth live
Property, auxiliary improves therapeutic effect.
Further, also include using steviol glycoside to make medicine.It is steviol glycoside to make medicine, is used as mouthfeel additive, regulation
All medicine foods will not make one to get fat with the mouthfeel with formula food.
Further, described monarch drug in a prescription, ministerial drug, adjutant, extract medicine compounding mixing after fermentation to concentrate and purify biological, extract
The active ingredients of each component, are finally made pressed candy with pressed form, the eating method chewed or swallowed.
In summary, the nutrition compound of assisting in preventing and treating cancer of the invention is using natural plants as raw material, selected no
The new resource food of what potential health hazard carries out compatibility, rationally reaches prevention and control of cancer and reduces toxic and side effects of chemoradiotherapy.Have
Following advantage:(1)It is steady to repair, without any toxic side effect.(2)Quick discharge degraded vivotoxin, anti-inflammatory analgesic is reduced and suffered from
Person's pain.(3)It can be given balanced nutritious with softening and dredging blood vessel, it is to avoid cancer complication.(4)Both chemicotherapy can received
Shi Tongyong, can also eat after chemicotherapy.(5)It effectively can recover and strengthen patient's immunity.(6)Can persistently it eat, you can
Prevention, again being capable of auxiliary treatment.
Embodiment
Embodiment 1
A kind of nutrition compound of assisting in preventing and treating cancer described by the embodiment of the present invention 1, using chlorella pyrenoidosa as monarch drug in a prescription, with
Herba Saussureae Involueratae culture is ministerial drug, using Agaricus Blazei Murrill polysaccharide as adjutant, and wherein the crude drug weight ratio of monarch drug in a prescription, ministerial drug and adjutant is 7:
2:1。
Monarch drug in a prescription is chlorella pyrenoidosa, rises and excludes toxin, and there is provided balanced nutritious effect for regulation acid-base balance;Pyrenoids is small
Ball algae is the general natural disposition monoplast green alga of green door Chlorella, and it is four that its vegetative propagation, which is one point, and about 20 hours, one slender
Born of the same parents are just split into four, there is extremely strong procreation ability.The anticancer that chlorella pyrenoidosa possesses is indicative more prominent, contains holography
Embryo differentiation accelerator is more, and anti-cancer and cancer-preventing is very competent, and it can promote holographic embryo of the diapause in cancer area to pass through cancer well
Area, carries out normal differentiation and development, so as to reach the purpose of anti-curing cancers.
Ministerial drug is Herba Saussureae Involueratae culture, auxiliary monarch drug in a prescription treatment main symptom, main softening and dredging blood vessel function.Herba Saussureae Involueratae is trained
Foster thing not only contains the active component close with natural snow lotus, and also has many pharmacological activity suitable therewith.It is led
Want pharmacological action analgesia, anti-inflammatory, antirheumatic;Suppress platelet aggregation, reducing blood lipid, improve blood circulation, have to immune system
Adjustment effect.
Adjutant is Agaricus Blazei Murrill polysaccharide, and Agaricus Blazei Murrill polysaccharide belongs to fungi polysaccharide, and energy strengthen immunity coordinates monarch-minister drug treatment simultaneous
Card.The antineoplastic component of Agricus blazei mainly has nucleic acid, lectin, sterol and aliphatic acid and polysaccharide.The polysaccharide body of Agricus blazei
Content is up to 6.55g/100g, is 5 times of ganoderma lucidum.Unique β-(1-6)- D- glucose structures, which are directly acted on, to be exempted from
Epidemic disease power, can fast lifting natural immunity cell growth activity, auxiliary improve therapeutic effect.
Also include using steviol glycoside to make medicine.It is steviol glycoside to make medicine, as mouthfeel additive, adjusts all medicine foods with use
The mouthfeel of formula food, will not make one to get fat.
The monarch drug in a prescription, ministerial drug, adjutant, extract medicine compounding mixing after fermentation to concentrate and purify biological, extract the activity of each component
Active ingredient, is finally made pressed candy with pressed form, the eating method chewed or swallowed.
The above described is only a preferred embodiment of the present invention, not making any form to the technology contents of the present invention
On limitation.Every any simple modification made according to technical spirit of the invention to above example, equivalent variations are with repairing
Decorations, in the range of still falling within technical scheme.
Claims (4)
1. a kind of nutrition compound of assisting in preventing and treating cancer, it is characterised in that using chlorella pyrenoidosa as monarch drug in a prescription, avenged with Tianshan Mountains
Lotus culture is ministerial drug, using fungi polysaccharide as adjutant, and wherein the crude drug weight ratio of monarch drug in a prescription, ministerial drug and adjutant is 7:2:1.
2. a kind of nutrition compound of assisting in preventing and treating cancer according to claim 1, it is characterised in that described fungi
Polysaccharide is Agaricus Blazei Murrill polysaccharide.
3. the nutrition compound of a kind of assisting in preventing and treating cancer according to claim 2, it is characterised in that also include with sweet tea
Synanthrin glycosides is to make medicine.
4. a kind of nutrition compound of assisting in preventing and treating cancer according to claim 3, it is characterised in that described monarch drug in a prescription,
Ministerial drug, adjutant, extract medicine compounding mixing after fermentation to concentrate and purify biological, extract the active ingredients of each component, finally with
Pressed candy is made in pressed form, the eating method chewed or swallowed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710149560.7A CN107007646A (en) | 2017-03-14 | 2017-03-14 | A kind of nutrition compound of assisting in preventing and treating cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710149560.7A CN107007646A (en) | 2017-03-14 | 2017-03-14 | A kind of nutrition compound of assisting in preventing and treating cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107007646A true CN107007646A (en) | 2017-08-04 |
Family
ID=59439888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710149560.7A Pending CN107007646A (en) | 2017-03-14 | 2017-03-14 | A kind of nutrition compound of assisting in preventing and treating cancer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107007646A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108477611A (en) * | 2018-03-13 | 2018-09-04 | 武春风 | A kind of compound chlorella composition for treating, preventing and/or repairing cancer |
CN108576792A (en) * | 2018-04-17 | 2018-09-28 | 江志正 | A kind of diet and preparation method thereof of compound chitosan oligosaccharide conditioning cancer |
CN110787193A (en) * | 2019-10-25 | 2020-02-14 | 青岛科海生物有限公司 | Chlorella effervescent tablet and preparation method thereof |
CN111357983A (en) * | 2020-03-23 | 2020-07-03 | 李永红 | Asparagus officinalis balanced nutrition health food composition |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101978974A (en) * | 2010-10-20 | 2011-02-23 | 汤永强 | Method for extracting bioactive substance by breaking walls of chlorella pyrenoidosa chick |
CN105011123A (en) * | 2015-08-05 | 2015-11-04 | 南京贝杉国际贸易有限公司 | Functional food for preventing tumor and assisting in anti-tumor treatment and preparing method thereof |
CN105380265A (en) * | 2015-11-06 | 2016-03-09 | 劲膳美生物科技股份有限公司 | Liver cancer medical formula food |
-
2017
- 2017-03-14 CN CN201710149560.7A patent/CN107007646A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101978974A (en) * | 2010-10-20 | 2011-02-23 | 汤永强 | Method for extracting bioactive substance by breaking walls of chlorella pyrenoidosa chick |
CN105011123A (en) * | 2015-08-05 | 2015-11-04 | 南京贝杉国际贸易有限公司 | Functional food for preventing tumor and assisting in anti-tumor treatment and preparing method thereof |
CN105380265A (en) * | 2015-11-06 | 2016-03-09 | 劲膳美生物科技股份有限公司 | Liver cancer medical formula food |
Non-Patent Citations (2)
Title |
---|
吕瑞凰: ""天山雪莲指纹图谱及总黄酮提取物研究"", 《硕士论文数据库》 * |
汪炬 等: ""蛋白核小球藻提取物的抑瘤作用及对免疫"", 《营养学报》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108477611A (en) * | 2018-03-13 | 2018-09-04 | 武春风 | A kind of compound chlorella composition for treating, preventing and/or repairing cancer |
CN108576792A (en) * | 2018-04-17 | 2018-09-28 | 江志正 | A kind of diet and preparation method thereof of compound chitosan oligosaccharide conditioning cancer |
CN110787193A (en) * | 2019-10-25 | 2020-02-14 | 青岛科海生物有限公司 | Chlorella effervescent tablet and preparation method thereof |
CN111357983A (en) * | 2020-03-23 | 2020-07-03 | 李永红 | Asparagus officinalis balanced nutrition health food composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107007646A (en) | A kind of nutrition compound of assisting in preventing and treating cancer | |
CN102160664A (en) | Nutritious drink for children | |
CN104432035B (en) | The health nutrient composition and method of making the same of enhancing immunity and application | |
CN104222638A (en) | Functional feed for preventing and treating carp branchiomycosis and preparation method of functional feed | |
CN105232623A (en) | Application of cyclocarya paliurus extract in preparation of medicine for treating stomach cancer | |
CN103251930A (en) | Nano-selenium and germanium vitamin pine tree-series multi-penis and testis medicinal liquor with functions of strengthening body and tonifying yang | |
CN104473286A (en) | Solid (functional) beverage synthesized from hibiacus esculengtus, fungi and alga and preparation method thereof | |
CN106236927A (en) | A kind of Chinese medicine composition with enhancing immunity and antifatigue effect and preparation method thereof and purposes | |
CN102813199A (en) | Health-care food for prevention and adjuvant therapy of cancer, three-high disease and immunity strengthening | |
CN105664140A (en) | Glycopeptide composition as well as preparation method and application thereof | |
CN104940241B (en) | A kind of selenium worm grass compound preparation of prevention climacteric metancholia of women | |
CN103908592A (en) | Traditional Chinese medicine for detoxification and preparation method of traditional Chinese medicine | |
CN105477100A (en) | Lucid ganoderma spore oil compound health care spray and preparation method | |
CN105030858A (en) | Cynomorium songaricum healthcare tablet and preparation method thereof | |
CN109043325A (en) | A kind of edible composite bacterium powder | |
CN104430720A (en) | Method for making functional biscuits through okra, fungus and algae plant mixtures | |
CN107233491A (en) | It is a kind of to improve the antifatigue maca composition of energy | |
CN101869329B (en) | Life-prolonging cancer-prevention healthcare beverage | |
CN104432305A (en) | Beverage with dietary therapy function and preparation method thereof | |
CN102885293A (en) | Spirulina health food and preparation method | |
CN107348082A (en) | A kind of Rosa roxburghii scented tea and preparation method thereof | |
US11089794B2 (en) | Method and composition for preparing a therapeutic natural tea remedy for helping the human body combat the effects of various medical ailments | |
CN106472908A (en) | Complexing calcium bamboo juice beverage and its production method | |
CN1179657C (en) | Immortal milk health tea | |
Basu et al. | Nutritional and Health Benefits of Singhara–A Review Article. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170804 |